Xtl Biopharmaceuticals (XTLB) EPS (Basic) Growth (3y) (2012 - 2024)
Xtl Biopharmaceuticals (XTLB) EPS (Basic) Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.43% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -179.42% |
| Sep 30, 2024 | 62.54% |
| Jun 30, 2024 | -37.38% |
| Mar 31, 2024 | 17.94% |
| Dec 31, 2023 | -8,461.42% |
| Sep 30, 2023 | 5,649.45% |
| Jun 30, 2023 | -6,903.36% |
| Dec 31, 2022 | -0.20% |
| Sep 30, 2022 | -4,606.81% |
| Jun 30, 2022 | -3,452.25% |
| Mar 31, 2022 | 1,940.26% |
| Dec 31, 2021 | 51.74% |
| Sep 30, 2021 | -7,397.02% |
| Mar 31, 2021 | 5,086.04% |
| Dec 31, 2020 | 95.57% |
| Sep 30, 2020 | -3.44% |
| Jun 30, 2020 | -34.92% |
| Dec 31, 2019 | -5,667.54% |
| Sep 30, 2019 | -2.14% |
| Jun 30, 2019 | -16.91% |